Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 787-793

  Schroterova L ^a   Haskova P ^b   Rudolf, E ^a   Cervinka, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Apoptosis; Colorectal cancer; Inositol; Phytic acid; Proliferation

Indexed keywords

CASPASE 3; INOSITOL; PHYTIC ACID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLORECTAL CARCINOMA; HUMAN; HUMAN CELL; METABOLIC ACTIVATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SYNTHESIS;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; HUMANS; INOSITOL; NEOPLASM PROTEINS; PHYTIC ACID;

EID: 77349115450     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000699     Document Type: Article

References (36)

1. Sakamoto K, Venkatraman G and Shamsuddin AM: Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis 14: 1815-1819, 1993.
2. Bozsik A, Kokeny S and Olah E: Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6). Cancer Genomics Proteomics 4: 43-51, 2007.
3. Cholewa K, Parfiniewicz B, Bednarek I, Swiatkowska L, Jezienicka E, Kierot J and Weglarz L: The influence of phytic acid on TNF-alpha and its receptors genes' expression in colon cancer Caco-2 cells. Acta Pol Pharm 65: 75-79, 2008.
4. Tantivejkul K, Vucenik I and Shamsuddin AM: Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells. Anticancer Res 23: 3671-3679, 2003.
5. Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal C and Agarwal R: In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Clin Cancer Res 10: 244-250, 2004.
6. Deliliers GL, Servida F, Fracchiolla NS, Ricci C, Borsotti C, Colombo G and Soligo D: Effect of inositol hexaphosphate (IP(6)) on human normal and leukaemic haematopoietic cells. Br J Haematol 117: 577-587, 2002.
7. Karmakar S, Banik NL and Ray SK: Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells. Neurochem Res 32: 2094-2102, 2007.
8. Zhang Z, Song Y and Wang XL: Inositol hexaphosphate-induced enhancement of natural killer cell activity correlates with suppression of colon carcinogenesis in rats. World J Gastroenterol 11: 5044-5046, 2005.
9. Tian Y and Song Y: Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line. World J Gastroenterol 12: 4137-4142, 2006.
10. Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I and Shamsuddin AM: IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res 18: 4083-4090, 1998.
11. Vucenik I, Zhang ZS and Shamsuddin AM: IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice. Anticancer Res 18: 4091-4096, 1998.
12. Shamsuddin AM and Vucenik I: Mammary tumor inhibition by IP6: a review. Anticancer Res 19: 3671-3674, 1999.
13. Vucenik I, Kalebic T, Tantivejkul K and Shamsuddin AM: Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo. Anticancer Res 18: 1377-1384, 1998.
14. Somasundar P, Riggs DR, Jackson BJ, Cunningham C, Vona-Davis L and McFadden DW: Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer. J Surg Res 126: 199-203, 2005.
15. Rizvi I, Riggs DR, Jackson BJ, Ng A, Cunningham C and McFadden DW: Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma. J Surg Res 133: 3-6, 2006.
16. Owen RW, Spiegelhalder B and Bartsch H: Phytate, reactive oxygen species and colorectal cancer. Eur J Cancer Prev 7 (Suppl 2): S41-S54, 1998.
17. El-Sherbiny YM, Cox MC, Ismail ZA, Shamsuddin AM and Vucenik I: G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res 21: 2393-2403, 2001.
18. Saied IT and Shamsuddin AM: Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res 18: 1479-1484, 1998.
19. Henneman PH, Forbes AP and Dudley HR: Idiopathic hypercalciuria. N Engl J Med 17: 802-807, 1958.
20. Shamsuddin AM, Ullah A and Chakravarthy AK: Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 10: 1461-1463, 1989.
21. Vucenik I, Yang GY and Shamsuddin AM: Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 16: 1055-1058, 1995.
22. Fox CH and Eberl M: Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Complement Ther Med 10: 229-234, 2002.
23. Vucenik I and Shamsuddin AM: Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr 133: 3778S-3784S, 2003.
24. Lee HJ, Lee SA and Choi H: Dietary administration of inositol and/or inositol-6-phosphate prevents chemically-induced rat hepatocarcinogenesis. Asian Pac J Cancer Prev 6: 41-47, 2005.
25. Vucenik I and Shamsuddin AM: Protection against cancer by dietary IP6 and inositol. Nutr Cancer 55: 109-125, 2006.
26. Shamsuddin AM, Yang GY and Vucenik I: Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res 16: 3287-3292, 1996.
27. Singh RP, Agarwal C and Agarwal R: Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinogenesis 24: 555-563, 2003.
28. Sharma G, Singh RP and Agarwal R: Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells. Int J Oncol 23: 1413-1418, 2003.
29. Yang GY and Shamsuddin AM: IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: Involvement of intracellular inositol phosphates. Anticancer Res 15: 2479-2487, 1995.
30. Shamsuddin AM and Yang GY: Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 16: 1975-1979, 1995.
31. Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P and Shamsuddin AM: Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis 25: 2115-2123, 2004.
32. Dorsey M, Benghuzzi H, Tucci M and Cason Z: Growth and cell viability of estradiol and IP-6 treated Hep-2 laryngeal carcinoma cells. Biomed Sci Instrum 41: 205-210, 2005.
33. McFadden DW, Riggs DR, Jackson BJ and Cunningham C: Corn-derived carbohydrate inositol hexaphosphate inhibits Barrett's adenocarcinoma growth by pro-apoptotic mechanisms. Oncol Rep 19: 563-566, 2008.
34. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326 (Pt 1): 1-16, 1997.
35. Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104, 1999.
36. Ferry S, Matsuda M, Yoshida H and Hirata M: Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway. Carcinogenesis 23: 2031-2041, 2002.